Journal
AMERICAN JOURNAL OF MEDICINE
Volume 120, Issue 8, Pages E18-658Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2006.09.031
Keywords
acute hyponatremia; brain edema; central pontine myelinolysis; chronic hyponatremia; exercise-associated hyponatremia; organic osmolytes; vasopressin; vasopressin receptor antagonist
Categories
Funding
- NHLBI NIH HHS [HL67963] Funding Source: Medline
- NIDDK NIH HHS [DK45666] Funding Source: Medline
Ask authors/readers for more resources
Hyponatremia is a common clinical problem in hospitalized patients and nursing home residents. It also may occur in healthy athletes after endurance exercise. The majority of patients with hyponatremia are asymptomatic and do not require immediate correction of hyponatremia. Symptomatic hyponatremia is a medical emergency requiring rapid correction to prevent the worsening of brain edema. How fast we should increase the serum sodium levels depends on the onset of hyponatremia and still remains controversial. If the serum sodium levels are corrected too rapidly, patients may develop central pontine myelinolysis, but if they are corrected too slowly, patients may die of brain herniation. We review the epidemiology and mechanisms of hyponatremia, the sensitivity of women to hyponatremic injury, the adaptation and maladaptation of brain cells to hyponatremia and its correction, and the practical ways of managing hyponatremia. Because the majority of hyponatremia is caused by the non-osmotic release of vasopressin, the recent approval of the vasopressin receptor antagonist conivaptan for euvolemic hyponatremia may simplify hyponatremia management. However, physicians should be aware of the risk of rapid correction of hyponatremia, hypotension, and excessive fluid intake. (c) 2007 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available